Adverse-event clearinghouse for compounding?

The National Association of Boards of Pharmacy has announced plans to develop a “national adverse-event reporting clearinghouse for compounded medications” that will “capture reports of patient harm and share that information among state boards of pharmacy and with the US Food and Drug Administration.” It’s still a ways off, though.